Press "esc" to clear
Go to Advanced Search

Showing results

4150 of 709
page_garde_gabay.jpg

Article ID: 690068

A Promising New Drug to Combat Serious Inflammatory Disease

Université de Genève (University of Geneva)

Still’s disease is a serious orphan disease manifested by high fevers, skin and joint involvement, including paralysis, as well as damage to other organs such as the liver or spleen.

Released:
27-Feb-2018 8:05 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
AdilHarroud2-2.jpg

Article ID: 690138

ACTRIMS Recognizes Young Investigators at Forum 2018

Americas Committee for Treatment and Research in Multiple Scleroses (ACTRIMS)

The Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) recognized the research contributions of five young investigators during the recent ACTRIMS Forum 2018. Abstracts and posters can be found in the ACTRIMS Forum online program, and will be published in the MS Journal.

Released:
26-Feb-2018 12:05 PM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Desai.jpg

Article ID: 690111

Discovery Reveals Way to Stop Inflammation in Alzheimer's, Arthritis, More

University of Virginia Health System

The finding “opens up a whole new research area to look at neuroinflammation in the context of Alzheimer’s and Parkinson’s,” the lead researcher says. “But the clinical impact will be in many, many different areas.”

Released:
26-Feb-2018 10:05 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 690057

Looking for an Off Switch for Celiac Disease

American Society for Biochemistry and Molecular Biology (ASBMB)

New research published in the Feb. 23 issue of the Journal of Biological Chemistry identifies an enzyme that turns off transglutaminase 2, potentially paving the way for new treatments for celiac disease.

Released:
23-Feb-2018 11:05 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 690044

Myositis Experts Available to Talk About Rare Disease Day

Myositis Association

Released:
23-Feb-2018 8:05 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 689503

Cuando el cuerpo ataca al cerebro: El sistema inmunitario generalmente es el culpable de la encefalitis, descubre estudio

Mayo Clinic

La encefalitis causada por el ataque del sistema inmunitario al cerebro tiene una frecuencia similar a la de la encefalitis producto de infecciones, informan los investigadores de Mayo Clinic en los Anales de Neurología.

Released:
13-Feb-2018 4:05 PM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 689366

When the Body Attacks the Brain: Immune System Often to Blame for Encephalitis, Study Finds

Mayo Clinic

ROCHESTER, Minn. — Encephalitis caused by the immune system attacking the brain is similar in frequency to encephalitis from infections, Mayo Clinic researchers report in Annals of Neurology.

Released:
12-Feb-2018 12:05 PM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
LuNatureMedicine.jpg
  • Embargo expired:
    12-Feb-2018 11:00 AM EST

Article ID: 689208

Experimental Therapy Restores Nerve Insulation Damaged by Disease

Cincinnati Children's Hospital Medical Center

When the body attacks its own healthy tissues in an autoimmune disease, peripheral nerve damage handicaps people and causes persistent neuropathic pain when insulation on healing nerves doesn’t fully regenerate. Unfortunately, there are no effective ways to treat the condition. Now scientists describe in Nature Medicine an experimental molecular therapy that restores insulation on peripheral nerves in mice, improves limb function, and results in less observable discomfort.

Released:
8-Feb-2018 11:30 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
VFBob_rs.jpg

Article ID: 688787

Vasculitis Foundation Establishes “VF Bob Day” February 1, 2018; Celebrating Longtime Volunteer’s Contributions with Global Awareness Initiative

Vasculitis Foundation

VF Bob is a new campaign launched by the Vasculitis Foundation to honor the late Bob Sahs, one of the organization's greatest awareness advocates. The goal of the campaign is to both spread awareness about autoimmune vasculitis, and to promote the work of the Vasculitis Foundation to support patients and fund research into vasculitis.

Released:
31-Jan-2018 9:05 PM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 688685

Rheumatology Leaders to HHS: Prior Authorization, Recent Part B Payment Change are Biggest Threats to Healthcare Choice and Competition

American College of Rheumatology (ACR)

The ACR urged HHS to reform its prior authorization policies, to reverse a recent HHS decision to apply Part B drug spending to payment adjustments under the Merit-Based Incentive Payment System (MIPS); require pharmacy benefit managers (PBMs) to be more transparent; and continue supporting biosimilar innovation.

Released:
30-Jan-2018 1:05 PM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

4150 of 709





Chat now!